ProShares Ultra 20+ Year Treasury UBT
Set alert
14.91 USD +0.24 +1.62%
As of Nov 2, 1:04 PM ET
14.78 Day range 14.91
12.83 52-week range 17.98
- YTD
- -9.92%
- 1 year
- -15.63%
- Open
- 14.76
- Prev close
- 14.67
- Mkt cap
- 56.09M
- Vol
- 65.57K
- Avg vol
- 93.84K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.78
- High
- 14.91
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 18.86
- 200-d avg
- 19.65
3M chart
Events in this range
- Sep 23, 2026Dividend: 0.11328
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 13, 2026 | 2 weeks ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 18.86
- 200-day average
- 19.65
About ProShares Ultra 20+ Year Treasury
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes publicly-issued U.S. Treasury securities that have a remaining maturity greater than or equal to twenty years and have $300 million or more of outstanding face value, excluding amounts held by the Federal Reserve. The fund is non-diversified.
News
- Novo Nordisk: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China
- Envestnet Asset Management Inc. Takes Position in ProShares Ultra 20+ Year Treasury $UBT
- The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
- UBT: Uncertainty Ignites Recession Fears - Bonds Could Rally
- UBT: Leveraged Exposure To 20-Year Treasuries Would Be Unwise Now
- UBT: The Contrarian Levered Play On Treasuries
- Understanding Bull And Bear Market Cycles With Jon Wolfenbarger
- Leveraged Treasury ETFs in Vogue on Rate Cut Bets
- UBT: If You Like Long Bonds Maybe You Should Like Them 2x
- Shiv Sena (UBT) MP seeks details of probe against Adani group companies from SEBI.
Your note
Sign in to keep a note on UBT — it syncs with the Stock Master app.